Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2208 to 2257 of 6456 in total 
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1104\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit d (ec 3.6.3.14) (v-atpase d subunit) (vacuolar proton pump d subunit) (v-atpase 28 kda accessory protein). [source:swissprot;acc:q9y5k8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.809\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1105\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adrenodoxin, mitochondrial precursor (adrenal ferredoxin) (hepatoredoxin) (ferredoxin 1). [source:swissprot;acc:p10109]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
191.139\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
185.882\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02828\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
secretory pathway component sec31b-1. [source:refseq;acc:nm\_015490]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.809\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1106\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
pxr2b protein. [source:refseq;acc:nm\_016559]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.945\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.109\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02818\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit h (ec 3.6.3.14) (v-atpase h subunit) (vacuolar proton pump h subunit) (v-atpase 50/57 kda subunits) (vacuolar proton pump subunit sfd) (cgi-11). [source:swissprot;acc:q9ui12]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.484\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.809\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1107\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine palmitoyltransferase 2 (ec 2.3.1.50) (long chain base biosynthesis protein 2) (lcb 2) (serine-palmitoyl-coa transferase 2) (spt 2). [source:swissprot;acc:o15270]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.603\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.324\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02796\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit b, kidney isoform (ec 3.6.3.14) (v- atpase b1 subunit) (vacuolar proton pump b isoform 1) (endomembrane proton pump 58 kda subunit). [source:swissprot;acc:p15313]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.483\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.676\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.807\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1108\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
interleukin enhancer-binding factor 1 (cellular transcription factor ilf-1). [source:swissprot;acc:q01167]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.006\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.119\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02775\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar atp synthase subunit f (ec 3.6.3.14) (v-atpase f subunit) (vacuolar proton pump f subunit) (v-atpase 14 kda subunit). [source:swissprot;acc:q16864]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.481\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.675\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.806\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1109\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 1 isoform c; epidermal growth factor receptor pathway substrate 8-related protein 1; eps8-related protein 1. [source:refseq;acc:nm\_139204]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.939\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.143\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.796\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
translationally controlled tumor protein (tctp) (p23) (histamine- releasing factor) (hrf). [source:swissprot;acc:p13693]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.098\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.209\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02775\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1110\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
arf gtpase-activating protein git2 (g protein-coupled receptor kinase- interactor 2). [source:swissprot;acc:q14161]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
216.78\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.782\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02769\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
ba305p22.3 (breast carcinoma amplified sequence 4). [source:sptrembl;acc:q8ndy6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
159.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
164.917\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.787\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1111\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis inhibitor fksg2. [source:swissprot;acc:q9hau6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
217.99\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.123\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02766\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
basic helix-loop-helix domain containing, class b, 5; trinucleotide repeat containing 20. [source:refseq;acc:nm\_152414]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
159.165\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
164.951\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.786\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1112\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor kinase substrate eps8. [source:swissprot;acc:q12929]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.93\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.146\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.784\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte nuclear factor 4-gamma (hnf-4-gamma). [source:swissprot;acc:q14541]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
251.863\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
258.829\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02766\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1113\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth arrest and dna-damage-inducible protein gadd45 gamma (cytokine responsive protein cr6). [source:swissprot;acc:o95257]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 7; sds22. [source:refseq;acc:nm\_002712]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
91.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
97.4011\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.7711\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1114\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
diphthamide biosynthesis-like protein 2. [source:refseq;acc:nm\_001384]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
227.274\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
233.041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.767\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
growth arrest and dna-damage-inducible protein gadd45 alpha (dna- damage inducible transcript 1) (ddit1). [source:swissprot;acc:p24522]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
251.863\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
258.829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02766\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1115\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase beta (ec 2.3.1.51) (1- agp acyltransferase 2) (1-agpat 2) (lysophosphatidic acid acyltransferase-beta) (lpaat-beta) (1-acylglycerol-3-phosphate o- acyltransferase 2). [source:swissprot;acc:o15120]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.664\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
180.943\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.721\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocyte nuclear factor 4-alpha (hnf-4-alpha) (transcription factor hnf-4) (transcription factor 14). [source:swissprot;acc:p41235]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
251.863\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
258.829\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02766\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1116\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
growth arrest and dna-damage-inducible protein gadd45 beta (negative growth-regulatory protein myd118) (myeloid differentiation primary response protein myd118). [source:swissprot;acc:o75293]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
serine palmitoyltransferase 2 (ec 2.3.1.50) (long chain base biosynthesis protein 2) (lcb 2) (serine-palmitoyl-coa transferase 2) (spt 2). [source:swissprot;acc:o15270]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
204.603\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.324\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.721\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1117\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 5 (tap-like protein 1) (tapl-1). [source:swissprot;acc:q9h1b4]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.989\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
164.46\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02754\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
steroid hormone receptor err2 (estrogen-related receptor, beta) (err-beta) (estrogen receptor-like 2) (err beta-2). [source:swissprot;acc:o95718]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.551\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
180.837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.714\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1118\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
epidermal growth factor receptor pathway substrate 8-like protein 2; eps8-related protein 2; epidermal growth factor receptor pathway substrate 8-related protein 2. [source:refseq;acc:nm\_022772]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.877\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
216.167\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.71\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 3 (tap-like protein 3) (tapl-3). [source:swissprot;acc:q9h4d5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
168.995\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
164.467\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02753\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1119\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxiredoxin 5, mitochondrial precursor (prx-v) (peroxisomal antioxidant enzyme) (plp) (thioredoxin peroxidase pmp20) (antioxidant enzyme b166) (aoeb166) (tpx type vi) (liver tissue 2d-page spot 71b) (alu co-repressor 1) (sbbi10). [source:swissprot;acc:p30044]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.553\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.256\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.703\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 2 (v-atpase 116-kda isoform a2) (tj6). [source:swissprot;acc:q9y487]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.528\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.676\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02752\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1120\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase alpha (ec 2.3.1.51) (1- agp acyltransferase 1) (1-agpat 1) (lysophosphatidic acid acyltransferase-alpha) (lpaat-alpha) (1-acylglycerol-3-phosphate o- acyltransferase 1) (g15 protein). [source:swissprot;acc:q99943]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.741\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
181.041\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.7\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal v0 subunit a isoform 4; vacuolar proton pump 116 kda accessory subunit; vacuolar proton pump, subunit 2; h(+)-transporting two-sector atpase, noncatalytic accessory protein 1b; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 1b; renal tubular acidosis; atpase, h+ transporting, lysosomal (vacuolar proton pump) non-catalytic accessory protein 2 (38kd). [source:refseq;acc:nm\_020632]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.528\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.676\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02752\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1121\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase gamma (ec 2.3.1.51) (1- agp acyltransferase 3) (1-agpat 3) (lysophosphatidic acid acyltransferase-gamma) (lpaat-gamma) (1-acylglycerol-3-phosphate o- acyltransferase 3). [source:swissprot;acc:q9nrz7]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
187.834\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
182.137\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.697\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 1 (clathrin-coated vesicle/synaptic vesicle proton pump 116 kda subunit) (vacuolar proton pump subunit 1) (vacuolar adenosine triphosphatase subunit ac116). [source:swissprot;acc:q93050]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.529\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.676\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02752\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1122\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein l (hnrnp l). [source:swissprot;acc:p14866]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
181.099\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.675\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
vacuolar proton translocating atpase 116 kda subunit a isoform 3 (v- atpase 116-kda isoform a3) (osteoclastic proton pump 116 kda subunit) (oc-116 kda) (oc116) (t-cell immune regulator 1) (t cell immune response cdna7 protein) (tirc7). [source:swissprot;acc:q13488]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.527\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.676\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02751\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1123\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
estrogen-related receptor gamma (estrogen receptor related protein 3) (err gamma-2). [source:swissprot;acc:o75454]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
186.799\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
181.127\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.672\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nuclear rna export factor 1 (tip associating protein) (tip-associated protein) (mrna export factor tap). [source:swissprot;acc:q9ubu9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
169.031\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
164.507\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.0275\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1124\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
kappa b-ras 1. [source:refseq;acc:nm\_020345]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.758\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.097\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.661\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
peroxiredoxin 5, mitochondrial precursor (prx-v) (peroxisomal antioxidant enzyme) (plp) (thioredoxin peroxidase pmp20) (antioxidant enzyme b166) (aoeb166) (tpx type vi) (liver tissue 2d-page spot 71b) (alu co-repressor 1) (sbbi10). [source:swissprot;acc:p30044]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
207.553\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
213.256\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
1.02748\vspace{3pt}}}\\\cline{1-2}\cline{4-5}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1125\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj718p11.1.2 (novel class ii aminotransferase similar to serine palmotyltransferase (isoform 2)) (fragment). [source:sptrembl;acc:q9ugb5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
204.404\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
210.022\vspace{3pt}}&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
i-kappa-b-interacting ras-like protein 2. [source:refseq;acc:nm\_017595]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.758\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.097\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.661\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1126\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
atpase, h+ transporting, lysosomal 38kda, v0 subunit d isoform 2. [source:refseq;acc:nm\_152565]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.487\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
212.656\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02742\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
snare associated protein snapin. [source:refseq;acc:nm\_012437]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.758\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.097\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.661\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1127\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein nop5 (nucleolar protein 5) (nop58) (hspc120). [source:swissprot;acc:q9y2x3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
239.219\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
232.837\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02741\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
sorting nexin 1. [source:swissprot;acc:q13596]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.868\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.522\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.654\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
1128\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1-acyl-sn-glycerol-3-phosphate acyltransferase delta (ec 2.3.1.51) (1- agp acyltransferase 4) (1-agpat 4) (lysophosphatidic acid acyltransferase-delta) (lpaat-delta) (1-acylglycerol-3-phosphate o- acyltransferase 4). [source:swissprot;acc:q9nrz5]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
187.96\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
182.308\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
5.652\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein six1 (sine oculis homeobox homolog 1). [source:swissprot;acc:q15475]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
Divided\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.286\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.399\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02733\vspace{3pt}}\\\cline{1-2}\cline{4-6}
\parbox{\wcA}{\vspace{3pt}\noindent
1129\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein six2 (sine oculis homeobox homolog 2). [source:swissprot;acc:q9npc8]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
221.285\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
215.401\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
1.02732\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/